Additionally, AP-1 directly regulates the expression of inflammatory cytokines and matrix-degrading matrix metalloproteinases (MMPs), which are involved in the pathogenesis of inflammation diseases and have emerged as new therapeutic targets, particularly in conditions like rheumatoid arthritis [52–55]. Here, JUN is linked to rheumatoid arthritis.